Skip to content
    RARE stock page

    Ultragenyx Pharmaceutical Inc.

    RARE · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 04, 2026

      Ultragenyx Q2 FY26 — Strong Commercial Performance and Key Pipeline Catalysts Ahead

      Read the brief

    Browse all US companies on the earnings-call register.